Blue Earth, MN (PRWEB) March 27, 2013
Express Diagnostics Int’l (EDI), manufacturer of DrugCheck® drugs of abuse testing devices, today announced the promotion of Gary Jueneman to senior executive vice president and general manager. In his new role, Jueneman will provide executive oversight of both EDI and IntraMed Diagnostics, LLC – a subsidiary of EDI – as well as continue to manage operations of the company’s Blue Earth, Minn., facility.
“Gary has been instrumental in driving sustained growth for EDI,” says Paul Johnson, CEO. “His extensive experience with, and comprehensive understanding of, supply chain management have enabled EDI to balance rapid expansion and new product development. With the creation of EDI’s subsidiary, IntraMed Diagnostics, Gary will be responsible for spearheading the design and implementation of advanced manufacturing capabilities for both EDI and IntraMed, as well as managing the projected additional growth for which these capabilities are being implemented.”
Jueneman joined EDI in 2010 as director of operations and was named vice president/general manager in 2011. EDI has experienced significant growth during Jueneman’s tenure in both production and facilities footprint. The EDI campus is now comprised of two facilities in the Blue Earth Industrial park, including over 36,000 sq. ft. of manufacturing, office, and warehouse space. Since beginning operations in 2004 with five employees, EDI has grown to employ over 80 people.
Jueneman welcomes the expanded role afforded by the promotion. “Working at EDI has been a challenging yet rewarding experience,” he says. “I appreciate the organization’s ongoing commitment to producing quality product while exploring new innovations. IntraMed and Express Diagnostics are poised to become premiere players in the drugs of abuse and health screening device markets and I look forward to breaking new ground.”
Express Diagnostics promotes Lueders and Wangen to Vice President roles
Express Diagnostics Int’l CEO Paul Johnson also announced today the promotions of Martin Lueders to vice president of quality systems and regulatory affairs and Aaron Wangen to vice president of marketing and communications. According to Johnson, “Both Martin and Aaron have had significant impact on the growth of EDI, and as IntraMed begins to develop additional products and technologies, we will rely on their expertise to define our presence in the diagnostics market.”
Lueders joined EDI in 2012 as director of quality systems and has led efforts to build a world-class quality system at the company, according to Gary Jueneman, senior executive vice president. “Thanks to Martin’s leadership and comprehensive understanding of quality and regulatory standards, the company has a robust quality system from which to pursue future growth. And he has been central to the development of similar systems at IntraMed.
“When Martin joined Express Diagnostics, IntraMed was simply a concept. We relied on his experience as a certified project management professional, in addition to his quality systems and regulatory expertise, to help bring IntraMed to fruition.
“Martin has strengthened our quality systems and oversees new product development to insure we meet all compliance and regulatory requirements,” says Jueneman. “He is instrumental in ensuring automation initiatives meet the highest production and quality standards.”
Wangen has served as marketing director at EDI since 2009 and worked on a contract basis for the company prior to joining the organization. Under his direction, the EDI marketing department provides complete marketing services internally, but also as a value-added service to Express Diagnostic distributors.
“Aaron has been central to building the DrugCheck brand and maintaining consistency throughout our communications,” says Rich Strasser, COO. “His extensive marketing communications background and comprehensive understanding of product positioning are invaluable assets. Aaron’s scope will expand as he develops brand and product strategies for IntraMed and future line extensions. His capabilities in market research and communicating the analysis to internal and external audiences allow us to define and pursue opportunities in a timely manner.”
Strasser adds, “We commend Martin and Aaron for their excellent work and outstanding contributions to EDI and look forward to continuing to benefit from their insight and experience in their new positions.”
About Express Diagnostics Int’l, Inc.
Express Diagnostics Int’l manufactures and distributes DrugCheck® on-site urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of health screening devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. Learn more at drugcheck.com.